BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10850303)

  • 1. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma.
    Williams JA; Yuan X; Dillehay LE; Shastri VR; Brem H; Williams JR
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):631-9. PubMed ID: 9806525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
    Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers.
    Yuan X; Fahlman C; Tabassi K; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):177-86. PubMed ID: 10850302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
    Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
    Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protracted exposure radiosensitization of experimental human malignant glioma.
    Williams JA; Williams JR; Yuan X; Dillehay LE
    Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
    Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
    J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts.
    Kinsella TJ; Vielhuber KA; Kunugi KA; Schupp J; Davis TW; Sands H
    Clin Cancer Res; 2000 Apr; 6(4):1468-75. PubMed ID: 10778979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier.
    Shirvalilou S; Khoei S; Khoee S; Mahdavi SR; Raoufi NJ; Motevalian M; Karimi MY
    J Photochem Photobiol B; 2020 Apr; 205():111827. PubMed ID: 32120183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
    Kinsella TJ; Kunugi KA; Vielhuber KA; Potter DM; Fitzsimmons ME; Collins JM
    Clin Cancer Res; 1998 Jan; 4(1):99-109. PubMed ID: 9516958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
    Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
    Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
    Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependent drug effects of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as an in vivo radiosensitizer in U251 human glioblastoma xenografts.
    Seo Y; Yan T; Schupp JE; Radivoyevitch T; Kinsella TJ
    Clin Cancer Res; 2005 Oct; 11(20):7499-507. PubMed ID: 16243824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
    Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
    Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-cerebral ventricular infusion of 5-iodo-2-deoxyuridine (IUDR) as a radiosensitizer in the treatment of a rat glioma.
    Deutsch M; Rewers AB; Redgate S; Fisher ER; Boggs SS
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):85-7. PubMed ID: 2380099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.